Evaluation of a Novel Prototype for Pressurized Intraperitoneal Aerosol Chemotherapy
暂无分享,去创建一个
J. C. Lee | G. Song | S. Park | W. Lim | Sunwoo Park | HeeSeung Kim | H. Paik | J. Mun | Eun Ji Lee | Junsik Kim | Soomin Ryu | H. Lee | S. Oh
[1] Ryan J. Hendrix,et al. Elevated Maximum Core Body Temperature During Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is Associated with Increased Postoperative Complications , 2019, Annals of Surgical Oncology.
[2] M. Hübner,et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. , 2019, The Lancet. Oncology.
[3] M. Stintz,et al. Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC) , 2017, Surgical Endoscopy.
[4] E. Förster,et al. Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model. , 2016, Anticancer research.
[5] W. Solass,et al. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[6] E. Förster,et al. Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) , 2016, Annals of Surgical Oncology.
[7] W. Solass,et al. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. , 2014, Gynecologic oncology.
[8] T. Chua,et al. Cure for peritoneal metastases? An evidence‐based review , 2013, ANZ journal of surgery.
[9] Urs Giger-Pabst,et al. Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy , 2013, Annals of Surgical Oncology.
[10] W. Solass,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.
[11] S. Loibl,et al. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] R. Gill,et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity , 2011, Journal of surgical oncology.
[13] D. Elias,et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Morel,et al. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator , 2009, Surgical Endoscopy.
[15] M. Flessner,et al. The transport barrier in intraperitoneal therapy. , 2005, American journal of physiology. Renal physiology.
[16] J. Mcvie,et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. , 1989, Cancer research.
[17] V. Devita,et al. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. , 1978, Cancer treatment reports.